Key NAFLD/NASH Studies Influencing My Practice Following EASL 2019

Join Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD, to review the latest practice-changing data from the 2019 meeting in Vienna! Hear his take on what you should be doing in your clinic and get answers to your questions in this interactive, CME/CE-certified Webinar.

Agenda

  • Program Overview (5 mins)
  • Updating My Practice Following Vienna 2019 (25 mins)
    • Summary of the most important studies on NAFLD/NASH
    • Key practice recommendations for the clinic
  • Question and Answer Session (15 mins)

Events

Date / Time
Event Details

Faculty

Faculty
Zobair Younossi, MD

Professor and Chairman
Department of Medicine
Inova Fairfax Medical Campus
Falls Church, Virginia

Goal Statement
The goal of this activity is to improve participants’ competence in translating the most clinically important data from EASL 2019 into practical management strategies for patients with NAFLD/NASH.

Target Audience
This program is intended for physicians, pharmacists, and other healthcare providers who care for patients with NAFLD/NASH.

Learning Objectives 

  • Integrate the results of recent clinical studies of NAFLD/NASH management strategies into clinical practice
  • Implement new data on strategies for diagnosing and managing NAFLD/NASH now and in the future

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation 

CCO designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education
CCO designates this continuing education activity for 0.75 contact hour (0.075 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-19-019-L01-P.

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.